HROW - HARROW, INC.
24.4
0.810 3.320%
Share volume: 1,284,543
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$23.59
0.81
0.03%
Summary score
17%
Profitability
1%
Dept financing
19%
Liquidity
68%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-300.73%
Return on assets
-6.1%
Return on sales
-24.91%
Return on invested capital
-79.28%
Total debt ratio
71.54%
Debt ratio change over timeo
0%
Current Ratio
2.05%
Quick Ratio
1.78%
Cash Position Ratio
0.53%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-30.99%
Return on assets
0.4%
Return on sales
-0.69%
Return on invested capital
-61.73%
Total debt ratio
61.2%
Debt ratio change over timeo
0%
Current Ratio
2.52%
Quick Ratio
2.26%
Cash Position Ratio
0.34%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-1.51%
Return on assets
-5.76%
Return on sales
-35.32%
Return on invested capital
-3.95%
Total debt ratio
68.2%
Debt ratio change over time
0%
Current Ratio
2.32%
Quick Ratio
2.03%
Cash Position Ratio
0.31%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | HROW | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | -300.73% | 17.45% | 4.69% | 19.89% |
Return on assets | -6.1% | 3.37% | 3.35% | 11.41% |
Return on sales | -24.91% | 23.96% | 25.96% | 42.05% |
Return on invested capital | -79.28% | 5.2% | 4.37% | -272.99% |
Profitability | 0% | 69% | 50% | 75% |
Total debt ratio | 71.54% | 77% | 57.66% | 53.92% |
Debt ratio change over time | 0% | 0% | 10.55% | 0% |
Dept financing | 23% | 25% | 44% | 18% |
Current Ratio | 2.52% | 1.16% | 1.27% | 1.05% |
Quick Ratio | 2.26% | 0.89% | 1.01% | 0.77% |
Cash Position Ratio | 0.34% | 0.17% | 0.53% | 0.31% |
Liquididy | 72% | 45% | 64% | 39% |
Short-term ratios | HROW | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | -30.99% | 44.06% | 6.24% | 17.3% |
Return on assets | 0.4% | 3.88% | 3.22% | 9.33% |
Return on sales | -0.69% | 27.04% | 24.93% | 40.02% |
Return on invested capital | -61.73% | 9.69% | 4.96% | -224.06% |
Profitability | 1% | 77% | 41% | 60% |
Total debt ratio | 61.2% | 91.8% | 61.39% | 55.88% |
Debt ratio change over time | 0% | 0% | 12.93% | 0% |
Dept financing | 17% | 25% | 42% | 15% |
Current Ratio | 2.52% | 1.16% | 1.27% | 1.05% |
Quick Ratio | 2.26% | 0.89% | 1.01% | 0.77% |
Cash Position Ratio | 0.34% | 0.17% | 0.53% | 0.31% |
Liquididy | 66% | 29% | 49% | 34% |